Oxford Science Enterprises Appoints Richard Laxer, Former Chairman and CEO of GE Capital, as a Non-Executive Director
OXFORD, England, April 19, 2022 /PRNewswire/ -- Oxford Science Enterprises, the Science Business Builder which transforms world-leading science from the University of Oxford into world-changing businesses, today announces the appointment of Richard Laxer to its Board of Directors, as an independent non-executive director.
Richard is a veteran of GE Capital, serving the company for 34 years before retiring in 2018 as CEO and Chairman. Richard held a number of senior executive roles at GE Capital across the US, Asia and Europe, leading global teams to develop and execute financing strategies that were critical to the success of a broad range of multi-billion-dollar world-leading businesses.
Since leaving GE Capital, Richard has used his experience and expertise to advise companies which are using cutting-edge and innovative technologies to disrupt the financial services industry. Richard has served as a senior advisor to Warburg Pincus and is currently a non-executive director to three of its portfolio companies: Vodeno Technology, Aion and Singular Bank.
"I am delighted to welcome Rich to the Board of Oxford Science Enterprises," said Chris Chambers, Chairman of the Board. "He has had a hugely successful career in the global financial services industry, where he has an exceptional record of growing and transforming a diverse portfolio of businesses, including start-ups. His financial expertise and extensive networks are a complementary addition to the Board, and I look forward to working with him to leverage his leadership and operational experience to support our portfolio of high potential technology and life science companies that are poised to make a positive change to the world."
"I am thrilled to be joining the Board of Oxford Science Enterprises," said Richard Laxer. "The pioneering science and technology advancing from the University of Oxford has significant potential to address some of the major global impact challenges that we face today. I am excited to support the company in its investments and to champion these new ventures into disruptive new enterprises."
Richard has proven experience navigating complex market conditions, managing enterprise risk alongside restructuring and integrating large businesses to deliver on financial targets. His extensive expertise of financing strategies includes, private equity, debt, corporate and commercial finance will be invaluable in directing Oxford Science Enterprises' global ambition of transforming world-leading science into a high value portfolio of world-changing businesses.
Richard joined GE Capital in 1984 after gaining a Bachelor's degree in Business, with a minor in Economics, from Skidmore College, Saratoga Springs, New York, US.
About Oxford Science Enterprises
We are Oxford Science Enterprises, the Science Business Builder. We want to help solve the world's toughest problems for more people, in more places, faster. We do this by transforming world-leading science into world-changing businesses, partnering the best scientists from the world's best university with the best business brains. We grow our companies with care and expertise; in a way that is systematic and scalable. We invest for real-world impact, not only financial returns. And we re-invest proceeds back into the next generation of original research and world-changing businesses.
Our enterprises address problems that affect people in life-changing ways: their health, the availability of food, the survival of the planet. Since 2015, we have received an automatic stake in all Oxford University science spinouts – more than 100 businesses founded by over 200 of Oxford's leading academics. We have taken a leading role in creating and building over 70 of these, adding +55,000 sq ft of lab & start-up space to support them. Today our businesses are worth over £2bn and have created +2,000 jobs.
Follow us: oxfordscienceenterprises.com | Twitter | LinkedIn | Quarterly News
Contacts:
Oxford Science Enterprises
Lisa Bedwell – lbedwell@oxfordsciences.com
For media enquiries:
Mark Swallow, Sandi Greenwood, Eleanor Perkin – MEDiSTRAVA Consulting
Share this article